Camelid nanobody anti-SARS-CoV-2 drug candidates

By | August 13, 2021
In a research paper recently published in the journal eLife, researchers from several US institutions have developed a nanobody-based candidate drug that effectively prevents and suppresses severe SARS-CoV-2 infection in animals.